Cargando…
Ovarian recurrence risk assessment using machine learning, clinical information, and serum protein levels to predict survival in high grade ovarian cancer
In ovarian cancer, there is no current method to accurately predict recurrence after a complete response to chemotherapy. Here, we develop a machine learning risk score using serum proteomics for the prediction of early recurrence of ovarian cancer after initial treatment. The developed risk score w...
Autores principales: | Mysona, David P., Purohit, Sharad, Richardson, Katherine P., Suhner, Jessa, Brzezinska, Bogna, Rungruang, Bunja, Hopkins, Diane, Bearden, Gregory, Higgins, Robert, Johnson, Marian, Bin Satter, Khaled, McIndoe, Richard, Ghamande, Sharad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684567/ https://www.ncbi.nlm.nih.gov/pubmed/38016985 http://dx.doi.org/10.1038/s41598-023-47983-z |
Ejemplares similares
-
Assessing for disparities in access to gynecologic oncology care during the COVID-19 pandemic at a single institution (453)
por: Suhner, Jessa, et al.
Publicado: (2022) -
Pure ovarian dysgerminoma in a postmenopausal patient: A case report and review of the management
por: Vaz, Jennifer, et al.
Publicado: (2022) -
A tale of two vulvar angiomyxomas: Two cases and review of literature
por: Navitski, Anastasia, et al.
Publicado: (2023) -
The COVID-19 pandemic did not adversely affect clinical trial enrollment in gynecologic oncology trials at a single academic institution
por: Bailey, Courtney, et al.
Publicado: (2022) -
Guillain-Barre Syndrome in a patient with uterine adenocarcinoma undergoing treatment with immune-checkpoint inhibitor therapy: A case report and review of the literature
por: Brzezinska, Bogna N., et al.
Publicado: (2021)